microdose vs regular dose glp-1 Full Therapeutic or Microdose: Which Plan Is Best For You? GLP-1 Microdosing: Why Smaller Doses

The Bottom Line: When in Doubt, Dont Risk It Look, I get it

The FDA is warning compounders against producing copies of GLP-1 drugs when they are no longer officially in shortage Some compounded versions may use different or unapproved salt forms of the active ingredient Concerns are growing around safety, quality, and consistency Significance: Compounding was allowed during shortages but that window may be closing Patients relying on cheaper alternatives could face disruption Pharma companies are moving to protect both patient safety and their IP This isnt just about enforcement its about control of one of the fastest-growing drug markets in history

The practical implication is that secretagogues work within the body's own feedback loops

BHRT helps reset the internal chemistry

Comparing tirzepatide (Mounjaro) and dulaglutide (Trulicity) The below chart outlines some of the key similarities and differences between once-weekly subcutaneous tirzepatide and dulaglutide